ATYR Q2 2021 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.64

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$398,000

Balance Sheet

Total Assets

$49M

Total Liabilities

$8M

Stockholders' Equity

$41M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$189,000	-100.0%
Gross Profit	$0	$189,000	-100.0%
Operating Income	-$10M	-$6M	-65.3%
Net Income	-$10M	-$6M	-61.2%